Tag: Impotence
Topical Gel for Erectile Dysfunction Gets FDA Approval for OTC Sale
Timeline for when the product will be in the United States is unknown, but it could be 2025
Erectile Function Mostly Not Impacted by Surgery for BPH
But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia
PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD
Among men with ischemic heart disease, coprescription of nitrates and PDE5 inhibitors not linked to increased risk for cardiovascular events
Erectile Dysfunction Meds Tied to Higher Risk for Vision Issues
Regular users may be at risk for serous retinal detachment, retinal vascular occlusion, and ischemic optic neuropathy
E-Cigarettes May Up the Risk for Erectile Dysfunction
Findings for men between 20 and 65 years of age with no prior history of cardiovascular disease
Concussion Symptom History Tied to Low Testosterone Levels
Past concussion and indicators for erectile dysfunction also linked in study of former football players
Erectile Dysfunction Tied to Lower Work Productivity Globally
Greater ED severity associated with worse outcomes for men worldwide
Erectile Dysfunction Presents Large Global Health Burden
Condition is risk factor for benign prostatic hyperplasia, cardiovascular disease, dementia
Effect of Shock Wave Treatment for Erectile Dysfunction Wanes
Only half of patients with initial treatment success maintain benefits at two years
Erectile Dysfunction Independently Tied to CV Events
ED a significant predictor of cardiovascular disease events after full adjustment for risk factors
